| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| F167654-5mg | 5mg | 3 | $75.90 | |
| F167654-25mg | 25mg | 3 | $313.90 | |
| F167654-50mg | 50mg | 2 | $522.90 | |
| F167654-100mg | 100mg | 2 | $871.90 |
| Synonyms | N-α-Fmoc-O-(2-Acetamido-2-deoxy-tri-O-acetyl-β-D-glucopyranosyl)-L-serine |
|---|---|
| Specifications & Purity | ≥95%(HPLC) |
| Biochemical and Physiological Mechanisms | In dynamic protein glycosylation, reversible O-GlcNAc modification of nuclear and cytoplasmic proteins at serine and threonine controls diverse aspects of cell physiology and is conceptually analogous to phosphorylation. |
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | A basic monosaccharide fragment of branched N-linked oligosaccharides found on |
| Pubchem Sid | 504766023 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504766023 |
| IUPAC Name | (2S)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid |
| INCHI | InChI=1S/C32H36N2O13/c1-16(35)33-27-29(46-19(4)38)28(45-18(3)37)26(15-42-17(2)36)47-31(27)43-14-25(30(39)40)34-32(41)44-13-24-22-11-7-5-9-20(22)21-10-6-8-12-23(21)24/h5-12,24-29,31H,13-15H2,1-4H3,(H,33,35)(H,34,41)(H,39,40)/t25-,26+,27+,28+,29+,31+/m0/s1 |
| InChi Key | ORICVOOXZDVFIP-ILRBKQRBSA-N |
| Canonical SMILES | CC(=O)NC1C(C(C(OC1OCC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)COC(=O)C)OC(=O)C)OC(=O)C |
| Isomeric SMILES | CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)COC(=O)C)OC(=O)C)OC(=O)C |
| PubChem CID | 11114983 |
| Molecular Weight | 656.63 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 B2309742 | Certificate of Analysis | Nov 25, 2022 | F167654 |
| B2309743 | Certificate of Analysis | Nov 25, 2022 | F167654 |
| B2309744 | Certificate of Analysis | Nov 25, 2022 | F167654 |
| B2309748 | Certificate of Analysis | Nov 25, 2022 | F167654 |
